MediciNova
MNOV
#9326
Rank
A$0.22 B
Marketcap
A$4.66
Share price
-3.77%
Change (1 day)
142.14%
Change (1 year)

Earnings for MediciNova (MNOV)

Earnings in 2026 (TTM): -A$17.52 Million

According to MediciNova's latest financial reports the company's current earnings are A$0.59 Million. In 2025 the company made an earning of -A$16.84 Million a decrease over its 2024 earnings that were of -A$15.51 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MediciNova from 2004 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$17.52 Million4.01%
2025 -A$16.84 Million8.58%
2024 -A$15.51 Million28.89%
2023 -A$12.04 Million-39.08%
2022 -A$19.76 Million38.83%
2021 -A$14.23 Million-26.88%
2020 -A$19.46 Million7.17%
2019 -A$18.16 Million-11.89%
2018 -A$20.61 Million13.68%
2017 -A$18.13 Million18.83%
2016 -A$15.26 Million22.91%
2015 -A$12.41 Million-3.93%
2014 -A$12.92 Million128.58%
2013 -A$5.66 Million-63.25%
2012 -A$15.38 Million-38.23%
2011 -A$24.9 Million-12.13%
2010 -A$28.33 Million-0.92%
2009 -A$28.6 Million-5.2%
2008 -A$30.17 Million-60.06%
2007 -A$75.52 Million29.03%
2006 -A$58.53 Million38.52%
2005 -A$42.25 Million-38.11%
2004 -A$68.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$22.16 B-134,843.60%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$43.70 B-265,805.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$10.75 B-65,478.30%๐Ÿ‡ซ๐Ÿ‡ท France
Titan Pharmaceuticals
TTNP
-A$3.94 Million-76.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.33 B-2,124.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$3.18 B-19,486.89%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel